- Home
- ALEC
ALEC
Alector Inc.
as 09-17-2025 4:00pm EST
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 124.0M | IPO Year: | 2019 |
| Target Price: | $4.50 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.87 - $6.37 | Next Earning Date: | 11-05-2025 |
| Revenue: | $81,130,000 | Revenue Growth: | 46.77% |
| Revenue Growth (this year): | -84.44% | Revenue Growth (next year): | 196.86% |
Stock Insider Trading Activity of Alector Inc. (ALEC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Rosenthal Arnon | ALEC | Chief Executive Officer | Sep 2 '25 | Sell | $2.50 | 51,562 | $128,740.00 | 2,350,220 | |
| Kenkare-Mitra Sara | ALEC | President and Head of R&D | Sep 2 '25 | Sell | $2.50 | 23,638 | $59,019.36 | 543,339 | |
| Wong-Sarad Grace | ALEC | Principal Accounting Officer | Sep 2 '25 | Sell | $2.50 | 5,910 | $14,756.09 | 103,448 | |
| Berkley Neil Lindsay | ALEC | Principal Financial Officer | Sep 2 '25 | Sell | $2.50 | 15,842 | $39,554.31 | 346,570 | |
| Hammond Paula | ALEC | N/A | Aug 26 '25 | Sell | $2.36 | 14,000 | $32,998.00 | 74,909 | |
| Yaffe Kristine | ALEC | Director | Jun 20 '25 | Sell | $1.44 | 1,000 | $1,440.00 | 95,409 |
Latest Alector Inc. News
ALEC Breaking Stock News: Dive into ALEC Ticker-Specific Updates for Smart Investing
MT Newswires
3 months ago
Alector Names Neil Berkley as Interim CFO
GlobeNewswire
3 months ago
Alector Provides Executive Leadership Update
GlobeNewswire
3 months ago
Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
Simply Wall St.
4 months ago
Top Penny Stocks To Watch In May 2025
Simply Wall St.
4 months ago
Alector, Inc. (NASDAQ:ALEC) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.26
Simply Wall St.
4 months ago
Alector First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
GlobeNewswire
4 months ago
Alector Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
4 months ago
Alector to Participate in Upcoming Healthcare Conferences
Compare ALEC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALEC Alector Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.